Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 230,466,108 papers from all fields of science
Search
Sign In
Create Free Account
Stage III Colon Cancer
Known as:
Stage III Colonic Carcinoma AJCC v6
, cancer colon iii stage
, colon cancer stage iii
Expand
Stage III includes: IIIA (T1-T2, N1, M0); IIIB (T3-T4, N1, M0); IIIC (Any T, N2, M0). N1: Metastasis in 1 to 3 regional lymph nodes. N2: Metastasis…
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
20 relations
APC gene
Abdominal Pain
BRAF gene
Colon structure (body structure)
Expand
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Effect of FOLFOX on minimal residual disease in Stage III colon cancer and risk of relapse
N. Murray
,
S. Aedo
,
+7 authors
Eghon Guzman
ecancermedicalscience
2019
Corpus ID: 195804061
Introduction 25% of Stage III colon cancer patients relapse within 5 years due to minimal residual disease (MRD) not eliminated…
Expand
2014
2014
Comment on Valerie Vrancken’s paper : ‘With the consent of the Estates…’ The political rights of the Estates of Brabant in the Inauguration Charters of the Brabantine dukes (1356-1494)
É. Bousmar
2014
Corpus ID: 152602524
Eric Bousmar, « Comment on Valerie Vrancken’s paper : ‘With the consent of the Estates…’ The political rights of the Estates of…
Expand
2013
2013
Abstract 4688: Landscape of DNA copy number alterations of stage III colon cancer in the ACTS-CC trial (TRICC0706), a phase III trial of adjuvant chemotherapy with S-1 and UFT/LV in Japan: A…
T. Ishikawa
,
H. Uetake
,
T. Kobunai
,
M. Ishiguro
,
S. Matsui
,
K. Sugihara
2013
Corpus ID: 58841155
Proceedings: AACR 104th Annual Meeting 2013; Apr 6-10, 2013; Washington, DC Background: The ACTS-CC trial is a phase III study…
Expand
2005
2005
FOLFOX for stage II colon cancer? A commentary on the recent FDA approval of oxaliplatin for adjuvant therapy of stage III colon cancer.
A. Grothey
,
D. Sargent
Journal of Clinical Oncology
2005
Corpus ID: 22245823
For almost 15 years, adjuvant chemotherapy has been known to improve disease-free survival (DFS) and overall survival (OS) in…
Expand
2003
2003
The Relationship between the Lymph Node Metastasis and the Prognosis of Patients with Dukes C Colon Cancer According to the Present and the Newly Proposed Japanese Classification of Colorectal…
H. Ishida
,
M. Tatsuta
,
+8 authors
H. Furukawa
2003
Corpus ID: 79179502
2002
2002
The Relationship between the Number of Metastatic Lymph Nodes and Prognosis of Patients with Dukes C Colon Cancer
H. Ishida
,
H. Furukawa
,
+7 authors
T. Satomi
2002
Corpus ID: 75257151
Background :The number of metastatic lymph nodes is considered an important prognostic factor in colorectal cancer in Europe and…
Expand
2001
2001
Therapeutic considerations in Dukes C colon cancer
W. Bleeker
2001
Corpus ID: 70743330
Colon cancer is one of the main health issues in the western world. In the Netherlands more than 7000 patients are diagnosed…
Expand
1997
1997
[A comparative study on p53 gene mutation in primary human Dukes C colon cancer with that in matched lymph node metastasis].
J. Zhang
,
S. Caplin
,
J. Benhattar
Zhonghua bing li xue za zhi = Chinese journal of…
1997
Corpus ID: 12349731
OBJECTIVE To study the relationship between metastasis of colon cancer and the mutation of p53 gene. METHODS PCR-SSCP was used…
Expand
1997
1997
Adjuvant chemotherapy of Dukes C colon carcinoma: Comparison of 5-FU + levamisole (LEV) 12 months vs
G. Hartung
,
K. Maas
,
+4 authors
W. Queisser
1997
Corpus ID: 53865947
1939
1939
Dukes Seang, Ch'aou, Ting, and Gae, with Tso's appendix, and the indexes
J. Legge
1939
Corpus ID: 118713358
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE
or Only Accept Required